Abiopharma

News list

Tennant Phil 🟢 acquired 125.0K shares (1 derivative) of PRECIGEN, INC. (PGEN) Transaction Date: Jun 26, 2025 | Filing ID: 007995

Full text

News bot Sept. 23, 2025, 10:20 a.m.
🔍 Tennant Phil (Executive)

Company: PRECIGEN, INC. (PGEN)

Report Date: 2025-06-26
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 125,000
Detailed Transactions and Holdings:
- Acquired 125,000 shares of Restricted Stock Units (Derivative)
  Date: 2025-06-26 | Code: A | equity_swap_involved: 0 | shares_owned_after: 125,000.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2
Footnotes:
- F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock.
- F2: The RSUs vest 50% on May 23, 2026 and in equal monthly installments for three years thereafter.